ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 127 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $485,910 | -12.5% | 19,018 | -1.8% | 0.00% | 0.0% |
| Q2 2023 | $555,503 | +13.1% | 19,369 | -5.5% | 0.00% | +100.0% |
| Q1 2023 | $491,049 | +27.1% | 20,486 | -10.1% | 0.00% | 0.0% |
| Q4 2022 | $386,400 | +7.6% | 22,783 | -5.9% | 0.00% | 0.0% |
| Q3 2022 | $359,000 | -2.2% | 24,214 | +3.8% | 0.00% | 0.0% |
| Q2 2022 | $367,000 | -49.8% | 23,323 | -13.9% | 0.00% | -50.0% |
| Q1 2022 | $731,000 | -35.5% | 27,100 | -11.5% | 0.00% | 0.0% |
| Q4 2021 | $1,134,000 | -30.2% | 30,631 | -9.9% | 0.00% | -33.3% |
| Q3 2021 | $1,625,000 | +77.2% | 34,000 | +25.5% | 0.00% | +50.0% |
| Q2 2021 | $917,000 | -18.1% | 27,100 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,119,000 | -15.4% | 27,100 | -11.1% | 0.00% | -33.3% |
| Q4 2020 | $1,323,000 | +47.5% | 30,500 | +45.9% | 0.00% | +50.0% |
| Q3 2020 | $897,000 | – | 20,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 208,886 | $5,337,037 | 1.71% |
| Portolan Capital Management | 276,505 | $7,064,703 | 0.66% |
| Nikko Asset Management Americas, Inc. | 1,388,574 | $35,422,523 | 0.42% |
| Green Alpha Advisors, LLC | 21,538 | $550,296 | 0.42% |
| SummerHaven Investment Management, LLC | 22,326 | $570,429 | 0.42% |
| ARK Investment Management | 1,901,546 | $48,584,508 | 0.37% |
| Granahan Investment Management | 398,862 | $10,190,924 | 0.36% |
| FEDERATED HERMES, INC. | 4,711,512 | $120,379,132 | 0.32% |
| Woodline Partners LP | 1,069,814 | $27,333,748 | 0.32% |
| Diametric Capital, LP | 26,130 | $667,621 | 0.28% |